RECENT PRESENTATIONS

1. "Pediatric Splanchnic Arterial Occlusive Disease: Clinical Relevance and Operative Treatment" read before the 25th Annual Meeting of the Midwestern Vascular Surgical Society, Chicago, Illinois, September 21, 2001 and presented at the 50th Scientific Meeting of the American Association for Vascular Surgery, Boston, Massachusetts, June 10, 2002.
2. "Risk Stratification of Diabetic Patients Undergoing Major Vascular Surgery" read before the 25th Annual Meeting of the Midwestern Vascular Surgical Society, Chicago, Illinois, September 21, 2001, and at the 48th Clinical Meeting of the Frederick A. Coller Surgical Society, Sea Island, Georgia, October 19, 2002.
3. "Prohibitive Failure Rate of Secondary and Tertiary Infrainguinal Arterial Reconstructions" read before the 25th Annual Meeting of the Midwestern Vascular Surgical Society, Chicago, Illinois, September 21, 2001.
4. "Visceral Artery Aneurysms" presented at the 19th Annual UCLA Symposium: A Comprehensive Review and Update of What’s New in Vascular Surgery, Santa Monica, California, October 3, 2001.
5. "Nitric Oxide Synthase Inhibition is Associated with Increased Matrix Metalloproteinase-9 Expression in Aortic Tissue" read before the 47th Clinical Meeting of the Frederick A. Coller Surgical Society, Galena, Illinois, October 5, 2001.
6. "Risk Stratification of Diabetic Patients Undergoing Major Vascular Surgery" presented at the 87th Annual Clinical Congress of the American College of Surgeons, Forum Session, New Orleans, Louisiana, October 10, 2001.
7. "Nitric Oxide Synthase Inhibition in Vitro is Associated with Increased Nuclear Factor-k? Activity in Rat Aortic Smooth Muscle Cells" presented at the 87th Annual Clinical Congress of the American College of Surgeons, Forum Session, New Orleans, Louisiana, October 10, 2001.
8. "Nitric Oxide Inhibition Increases Aortic Wall Matrix Metalloproteinase-9 Expression" read before the 35th Annual Meeting of the Association for Academic Surgery, Milwaukee, Wisconsin, November 16, 2001.
9. "Durability of Saphenous Vein Arterial Grafts in Children" presented at the 28th Annual Symposium on Vascular and Endovascular Issues, Techniques and Horizons (Albert Einstein College of Medicine), New York, New York, November 17, 2001.
10. "Individual Surgeon Volume as an Indicator of Outcome Following Carotid Endarterectomy Independent of Surgical Practice" read before the 63rd Annual Meeting of the Society of University Surgeons", Honolulu, Hawaii, February 14, 2002.
11. "Endovascular Treatment of Abdominal Aortic Aneurysms is Associated with a Low Incidence of Deep Venous Thrombosis" read before the 14th Annual Meeting of the American Venous Forum, La Jolla, California, February 24, 2002.
12. "Elective and Emergent Abdominal Aortic Aneurysmectomy in Patients with Coexisting Aortic Dissection: Perioperative and 1-Year Survival Rates" read before the 30th Annual Meeting of the Society for Clinical Vascular Surgery, Las Vegas, Nevada, March 15, 2002.
13. "Renal Artery Occlusive Disease and Renovascular Hypertension: Recognition and Contemporary Therapy" presented as the Kredel-Springs Lecture at the Medical University of South Carolina, Charleston, South Carolina, March 22, 2002.
14. "A Nonintrinsic Regional Basis for Increased Infrarenal Aortic MMP-9 Expression and Activity" presented at the Research Initiatives in Vascular Disease Conference, Bethesda, Maryland, April 18, 2002.
15. "Vascular Surgery Workforce Issues and Training of Vascular Surgeons" read before the 56th Annual Meeting of the Society for Vascular Surgery, Boston, Massachusetts, June 11, 2002.
16. "Carotid Disease: Surgery or Stents" presented at the American College of Cardiology 4th Annual Yellowstone Summit on Cardiovascular Care: Integrating Evidence-Based Care into Practice, West Yellowstone, Montana, August 7, 2002.
17. "Peripheral Vascular Disease Should be Preferentially Treated with Angioplasty and Stents: Antagonist Perspective" presented at the American College of Cardiology 4th Annual Yellowstone Summit on Cardiovascular Care: Integrating Evidence-Based Care into Practice, West Yellowstone, Montana, August 7, 2002.
18. "Stents for Renovascular Hypertension: Antagonist Perspective" presented at the American College of Cardiology 4th Annual Yellowstone Summit on Cardiovascular Care: Integrating Evidence-Based Care into Practice, West Yellowstone, Montana, August 7, 2002.
19. "Endovascular Stents for Complex Aortic Disease" presented at the American College of Cardiology 4th Annual Yellowstone Summit on Cardiovascular Care: Integrating Evidence-Based Care into Practice, West Yellowstone, Montana, August 7, 2002.
20. "Hospital Volume and Mortality After Aortobifemoral Bypass in the United States" read before the 26th Annual Meeting of the Midwestern Vascular Surgical Society, Madison, Wisconsin, September 13, 2002.
21. Iliorenal Bypass: An Effective Alternative to Aortorenal Reconstruction in Select Patients with Renovascular Occlusive Disease" presented as a poster at the 26th Annual Meeting of the Midwestern Vascular Surgical Society, Madison, Wisconsin, September 13, 2002, and the 48thClinical Meeting of the Frederick A. Coller Surgical Society, Sea Island, Georgia, October 19, 2002.
22. "The NO Donor DETA-NONOate Decreases MMP-9 Expression and Activity" presented as a poster at the 26th Annual Meeting of the Midwestern Vascular Surgical Society, Madison, Wisconsin, September 13, 2002.
23. "Visceral Artery Aneurysms" presented at the 20th Annual UCLA Symposium: A Comprehensive Review and Update of What's New in Vascular Surgery, Beverly Hills, California, October 3, 2002.
24. "Surgical Treatment of Intact Thoracoabdominal Aortic Aneurysms in the United States: Provider Volume and Outcome" read before the 29th Annual Meeting of the New England Society for Vascular Surgery, Rockport, Maine, October 5, 2002.
25. "The Ignoble Renal Artery, Renin, Angiotensin, Hypertension, and the Surgeon Scientist" presented as the I.S. Ravdin Lecture in the Basic Sciences, at the American College of Surgeons 88th Clinical Congress, San Francisco, California, October 9, 2002.
26. "Provider Volume and Surgeon Specialty are Related to Outcomes of Abdominal Aortic Aneurysm Repair in the United States" presented at the 36th Annual Meeting of the Association for Academic Surgery, Boston, Massachusetts, November 7, 2002.
27. "Comparative Study of Transabdominal Ultrasonography and Video Microscopy Measurements of Aortic Diameters in Rat and Mouse Models of Aneurysm Disease" presented at the 36th Annual Meeting of the Association for Academic Surgery, Boston, Massachusetts, November 8, 2002.
28. "Diagnosis and Management of Renovascular Hypertension" presented at the 137th Annual Scientific Meeting of the Michigan State Medical Society, Troy, Michigan, November 8, 2002.
29. "Recognition and Management of Renovascular Hypertension" presented as the Distinguished Paul E. Stanton Jr. Lecture, at the James H. Quillen College of Medicine, East Tennessee State University, Mountain Home, Tennessee, November 16, 2002.
30. "Prohibitive Failure Rates of Secondary and Tertiary Infrainguinal Arterial Reconstructions" presented at the 29th Annual Symposium on Vascular and Endovascular Issues, Techniques and Horizons (Albert Einstein College of Medicine), New York, New York, November 22, 2002.
31. "Bypass Graft in Pediatric Population" presented at a Symposium on Trends in Vascular Surgery 2002 (Northwestern University), Chicago, Illinois, December 13, 2002.
32. "Payer-Related Differences in Access and Outcome of Abdominal Aortic Aneurysm Repair" read before the 64th Annual Meeting of the Society of University Surgeons, Houston, Texas, February 13, 2003.
33. "The Presence and Evolution of Abdominal Aortic Aneurysms in Patients with Thoracic Aortic Dissection" read before the 31st Annual Meeting of the Society for Clinical Vascular Surgery, Miami, Florida, March 6, 2003.
34. "Variation in Postoperative Complication Rates After High-Risk Surgery in the United States" read before the 60th Annual Meeting of the Central Surgical Association, Toronto, Canada, March 20, 2003.
35. "Carotid Endarterectomy is Safe in High-Risk Surgical Patients" read before the 28th Annual Scientific Meeting of the Society of Interventional Radiology, Salt Lake City, Utah, March 31, 2003.
36. "Renal Artery Stenosis: When to Revascularize" presented at the 52nd Annual Scientific Session of the American College of Cardiology, Chicago, Illinois, April 1, 2003.
37. "A National and Individual Institutional Experience in the Contemporary Treatment of Acute Embolic Limb Ischemia" read before the 123rd Annual Meeting of the American Surgical Association, Washington, DC, April 25, 2003.
38. "Renovascular Disease" presented at an Educational Course on Vascular and Thoracic Diseases (Michigan State University, College of Osteopathic Medicine), East Lansing, Michigan, April 30, 2003.
39. "Neutrophil Depletion Inhibits Experimental Aortic Aneurysm Formation Unrelated to MMP-2 and MMP-9" read before the Lifeline Foundation Research Forum, 57th Annual Meeting of the Society for Vascular Surgery, Chicago, Illinois, June 8, 2003.
40. "Risk of Stroke Following Non-Carotid Artery Vascular Surgery" read before the 57th Annual Meeting of the Society for Vascular Surgery, Chicago, Illinois, June 9, 2003.
41. "Patients with Operative Peripheral Vascular Occlusive Disease are Underprescribed Cardioprotective Medications: Effect on Graft Patency, Limb Salvage, and Mortality" read before the 51st Scientific Meeting of the American Association for Vascular Surgery, Chicago, Illinois, June 10, 2003.
42. "Predicting Safe Early Discharge Following Carotid Endarterectomy: Factors Contributing to Blood Pressure Instability" read before the 27th Annual Meeting of the Midwestern Vascular Surgical Society, Chicago, Illinois, September 20, 2003.
43. "Visceral Artery Aneurysms" presented at the 21st Annual UCLA Symposium: A Comprehensive Review and Update of What's New in Vascular Surgery, Beverly Hills, California, October 1, 2003.
44. "Patients with Operative PVOD are Underprescribed Cardioprotective Medications: Effect on Graft Patency, Limb Salvage and Mortality" read before the 49th Clinical Meeting of the Frederick A. Coller Surgical Society, Asheville, North Carolina, October 10, 2003.
45. "Neutrophil Depletion Inhibits Experimental Aortic Aneurysm Formation Unrelated to MMP-2 and MMP-9" read before the 49th Clinical Meeting of the Frederick A. Coller Surgical Society, Asheville, North Carolina, October 10, 2003.
46. "The NO Donor DETA-NONOate Decreases MMP-9 Expression and Activity in the Abdominal Aortic Explants and Rat Aortic Smooth Muscle Cells" read before the 49tth Clinical Meeting of the Frederick A. Coller Surgical Society, Asheville, North Carolina, October 11, 2003.
47. "Complex Renal Artery Aneurysmectomy" presented at the 89th Clinical Congress of the American College of Surgeons, Vascular Surgery Video Session, Chicago, Illinois, October 21, 2003.
48. "Effect of Increasing Patient Age on the Role of Complications After Repair of Intact Abdominal Aortic Aneurysms" read before the 37th Annual Meeting of the Association for Academic Surgery, Sacramento, California, November 14, 2003.
49. "The NO Donor DETA-NONOate Decreases MMP-9 Expression and Activity in Abdominal Aortic Explants" read before the 37th Annual Meeting of the Association for Academic Surgery, Sacramento, California, November 15, 2003.
50. "Present Status of the American Board of Vascular Surgery" presented at the 30th Annual Symposium on Vascular and Endovascular Issues, Techniques and Horizons (Albert Einstein College of Medicine), New York, New York, November 22, 2003.
51. "Management of AAAs in Patients with a Thoracic Aortic Dissection" presented at the 30th Annual Symposium on Vascular and Endovascular Issues, Techniques and Horizons (Albert Einstein College of Medicine), New York, New York, November 23, 2003.